Bibi Wishart, PharmD
Third-party administrators (TPAs) have long been one of the most essential partners for hospitals and health systems participating in the federal 340B Drug Pricing Program. Their tools and support help ensure covered entities (CEs) remain compliant with statutory requirements and the increasingly complex and evolving mandates imposed by drug manufacturers.
Without TPAs’ split-billing software for 340B-eligible claims qualification and inventory management,